Han, Jian
Zhang, Nana
Cao, Qiqi
Shi, Xiaodan
Wang, Congjing
Rui, Ximan
Ding, Jie
Zhao, Chun
Zhang, Junqiang
Ling, Xiufeng
Li, Hong
Guan, Yichun
Meng, Qingxia
Funding for this research was provided by:
National Natural Science Foundation of China (32070838)
Qinglan Project of Jiangsu Province of China
National Key Research and Development Program of China (2022YFC2702201)
Open Fund of State Key Laboratory of Reproductive Medicine, Nanjing Medical University (SKLRM K202102)
Article History
Received: 12 October 2022
Revised: 10 April 2023
Accepted: 12 April 2023
First Online: 6 May 2023
Declarations
:
: This study was approved by the Ethics Committee of the Nanjing Medical University (2018/651), the Ethics Committee of Women’s Hospital of Nanjing Medical University (KY-025), the Ethics Committee of Suzhou Municipal Hospital (2020001), and the Ethics Committee of The Third Affiliated Hospital of Zhengzhou University (no.2020–61). Human oocytes and embryos for RT-qPCR were obtained from the Center for Reproductive Medicine, The First Hospital of Anhui Medical University (2021H041). Mouse experiments were carried out according to and with the approval of the Institutional Animal Care and Use Committee of Nanjing Medical University, China. All procedures involving the mice were carried out according to the Guide for the Care and Use of Laboratory Animals (National Research Council, 2011).
: Informed consent was obtained from the patients, their parents, and other family members involved in this study. All contributors provided written informed consent to participate in this study.
: Written informed consent for publication was obtained for this manuscript.
: The authors declare no competing interests.